This page lists the paediatric cardiology hospitals in our directory offering Tetralogy of Fallot (TOF) in Bengaluru, India, including Narayana Health, Manipal Hospitals, Medicover Hospital, Bangalore, Gleneagles Hospitals, Bengaluru and others. Each listing links through to the hospital's full profile page.
Ask us about tetralogy of fallot (tof) in Bengaluru, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 10 accredited hospitals for Paediatric Cardiology in Bengaluru, India
Featured🇮🇳 Narayana Health
Ranks #1 in this list by listed rating (4.8/5 from 1750 reviews).
🇮🇳 Manipal Hospitals
Ranks #2 in this list by listed rating (4.7/5 from 1450 reviews).
🇮🇳 Medicover Hospital, Bangalore
Ranks #3 in this list by listed rating (4.7/5 from 68 reviews).
🇮🇳 Gleneagles Hospitals, Bengaluru
Ranks #4 in this list by listed rating (4.7/5 from 142 reviews).
🇮🇳 Manipal Hospital Malleshwaram (Northside)
Ranks #5 in this list by listed rating (4.6/5 from 71 reviews).
🇮🇳 Manipal Hospital, Old Airport Road
Ranks #6 in this list by listed rating (4.5/5 from 87 reviews).
🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)
Ranks #7 in this list by listed rating (4.5/5 from 98 reviews).
🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)
Ranks #8 in this list by listed rating (4.4/5 from 74 reviews).
🇮🇳 Apollo Hospital, Bannerghatta Road
Ranks #9 in this list by listed rating (4.2/5 from 25 reviews).
🇮🇳 Fortis Hospital, Bannerghatta Road
Ranks #10 in this list by listed rating (4.2/5 from 58 reviews).
How we selected these hospitals
A hospital appears on this page when Paediatric Cardiology is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Tetralogy of Fallot (TOF) in Bengaluru, India?
Choosing the right hospital for tetralogy of fallot (tof) is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include paediatric cardiology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Tetralogy of Fallot (TOF)
Tetralogy of Fallot (TOF) repair is a definitive open-heart surgical procedure that corrects four congenital cardiac defects simultaneously — ventricular septal defect (VSD) closure, right ventricular outflow tract (RVOT) reconstruction, pulmonary valve repair or replacement, and correction of aortic override — restoring near-normal pulmonary and systemic circulation in affected children and adults. With long-term survival rates exceeding 90% at 30 years in high-volume pediatric cardiac centers, TOF repair is one of the most studied and successful congenital heart surgeries performed globally. GAF Healthcare connects international families with India's and the UAE's foremost JCI- and NABH/DHA-accredited pediatric cardiac institutions, offering world-class surgical outcomes, full care coordination, and significant cost savings compared to Western healthcare systems. Hospital Stay: 10–16 days (including 3–5 days in the Pediatric Cardiac ICU followed by 7–11 days on the cardiac ward) • Total Stay in Country (Fit-to-Fly): 4–6 weeks post-surgery before clearance for international air travel, subject to the treating cardiologist's final echocardiographic assessment • Success Rate: 92–96% (30-day surgical survival at high-volume JCI/NABH-accredited centers)
Clinical Overview
Tetralogy of Fallot is the most common cyanotic congenital heart disease, accounting for approximately 7–10% of all congenital cardiac defects and affecting roughly 1 in every 2,500 live births. The pathology is defined by four co-existing anatomical abnormalities: (1) a large, malaligned ventricular septal defect (VSD) that allows deoxygenated blood to mix with oxygenated blood; (2) infundibular and/or valvular pulmonary stenosis creating right ventricular outflow tract (RVOT) obstruction; (3) an overriding aorta positioned directly above the VSD, receiving blood from both ventricles; and (4) right ventricular hypertrophy (RVH) secondary to the pressure overload imposed by the obstructed outflow. The net physiological consequence is chronic arterial hypoxemia, failure to thrive, episodic hypercyanotic 'Tet spells,' and, if left uncorrected, progressive polycythemia, paradoxical embolism, and premature death. Risk stratification tools including the Aristotle Basic Complexity (ABC) Score and the Society of Thoracic Surgeons–European Association for Cardio-Thoracic Surgery (STS-EACTS) Congenital Heart Surgery Mortality Score are routinely used to classify operative risk and guide surgical planning. The contemporary standard of care is complete intracardiac repair, ideally performed electively between 3 and 6 months of age (though presentation in older children or adults remains surgically correctable). The procedure is executed via median sternotomy with the patient on cardiopulmonary bypass (CPB) using moderate hypothermia (28–32°C). The surgical correction involves: patch closure of the VSD using a Dacron or autologous pericardial patch; resection of obstructive infundibular muscle bundles (subvalvular resection); pulmonary valvotomy or pulmonary valve–sparing RVOT reconstruction where feasible; and, when the pulmonary annulus is severely hypoplastic (Z-score ≤ −2 to −3), placement of a transannular patch (TAP) — the most common cause of resultant pulmonary regurgitation (PR) in long-term follow-up. In select neonates with severe cyanosis or anatomically unfavorable TOF (including TOF with pulmonary atresia), a palliative Blalock–Taussig–Thomas (BTT) shunt or right ventricle–to–pulmonary artery (RV-PA) conduit may be placed as a bridge to definitive repair. Long-term surveillance is lifelong. Hemodynamically significant pulmonary regurgitation — the most prevalent late sequela of transannular patch repair, occurring in 70–80% of patients — may progress to RV dilation and dysfunction, necessitating pulmonary valve replacement (PVR) one to three decades after initial repair. Catheter-based options, most notably transcatheter pulmonary valve replacement (TPVR) using the Melody™ or SAPIEN XT™ valve systems, have transformed the management of late PR in appropriately selected patients, deferring or replacing the need for redo open-heart surgery. Centers of excellence in India and the UAE are fully equipped to perform both primary TOF repair and transcatheter or surgical PVR, with dedicated adult congenital heart disease (ACHD) programs staffed by cardiologists holding international subspecialty credentials.
Who is a Candidate?
• ELIGIBLE PATIENTS — PEDIATRIC: • Neonates and infants (3–12 months) with confirmed TOF on echocardiography, presenting with cyanosis (SpO2 < 85%), failure to thrive, or recurrent hypercyanotic spells • Children aged 1–10 years with unrepaired or incompletely palliated TOF (post-BTT shunt or RV-PA conduit) deemed ready for complete intracardiac repair • Patients with TOF variants including TOF with pulmonary atresia (TOF/PA), TOF with absent pulmonary valve syndrome (TOF/APV), and TOF with atrioventricular septal defect (TOF/AVSD) • ELIGIBLE PATIENTS — ADOLESCENT/ADULT (ACHD): • Patients with previously repaired TOF and hemodynamically significant free pulmonary regurgitation (RVESVI > 80 mL/m², RVEDVI > 150–160 mL/m² on cardiac MRI) • Adults with residual VSD (Qp:Qs ≥ 1.5:1), residual RVOTO (peak Doppler gradient > 40 mmHg), or significant tricuspid regurgitation • Candidates for transcatheter pulmonary valve replacement (TPVR) with suitable RVOT conduit morphology (conduit diameter ≥ 16 mm) • REQUIRED DIAGNOSTIC WORKUP: • Two-dimensional and Doppler echocardiography (transthoracic ± transesophageal): anatomy of VSD, RVOT, pulmonary valve annulus Z-score, aortic override, coronary artery anatomy • Cardiac MRI (CMR): gold standard for quantifying RV volumes (RVEDVI, RVESVI), ejection fraction, and degree of pulmonary regurgitation (regurgitant fraction >25% is clinically significant) • Cardiac catheterization with angiography: pulmonary artery anatomy, pulmonary artery pressures, coronary anatomy (especially anomalous left anterior descending from right coronary artery — present in ~5% of TOF cases, mandating surgical strategy modification) • CT angiography (CTA): pulmonary artery branch anatomy, conduit calcification assessment for TPVR candidates • Complete blood count (CBC): polycythemia, iron-deficiency anemia • Coagulation profile (PT, aPTT, INR): pre-CPB assessment • Chromosomal microarray / FISH for 22q11.2 deletion (DiGeorge syndrome): present in ~15–20% of TOF cases; affects immunological management and calcium homeostasis perioperatively • Genetic testing / next-generation sequencing panel if syndromic features (Down syndrome, CHARGE, Alagille) are present • Chest X-ray: classic 'boot-shaped heart' (coeur en sabot) • 12-lead ECG and Holter monitoring: right bundle branch block (RBBB), QRS duration (a QRS duration > 180 ms is an independent risk factor for sudden cardiac death in repaired TOF) • CONTRAINDICATIONS / HIGH-RISK FEATURES: • Severe, fixed pulmonary arterial hypertension (PAH) with Eisenmenger physiology (pulmonary vascular resistance index >8 Wood units·m² unresponsive to vasodilator testing) — absolute contraindication to VSD closure • Active systemic infection or sepsis prior to elective repair • Prohibitively elevated operative risk due to severe comorbidities (e.g., advanced hepatic or renal failure in ACHD patients) • Severely hypoplastic pulmonary arteries with Nakata index < 150 mm²/m² may require staged unifocalization prior to complete repair in TOF/PA with major aortopulmonary collateral arteries (MAPCAs)
Treatment Options & Approaches
TOF repair encompasses a spectrum of interventions ranging from palliative neonatal procedures to definitive intracardiac repair and, subsequently, late reintervention for residual or recurrent lesions. 1. PALLIATIVE PROCEDURES (Bridge to Complete Repair): • Modified Blalock–Taussig–Thomas (mBTT) Shunt: A 3.5–4 mm Gore-Tex interposition graft connecting the subclavian artery to the ipsilateral pulmonary artery, performed in critically cyanotic neonates (<3 kg) unfit for primary repair. Improves pulmonary blood flow and allows somatic growth before definitive surgery. • Central Aortopulmonary Shunt: Used when subclavian anatomy is unfavorable. • RV-to-PA Conduit (Sano modification): Preferred in TOF/PA to provide forward pulsatile pulmonary flow. • Pulmonary Balloon Valvuloplasty: Occasionally used as palliation in selected cases with predominantly valvular obstruction. 2. COMPLETE INTRACARDIAC REPAIR (DEFINITIVE — PRIMARY TREATMENT): • Operative Access: Standard median sternotomy with cardiopulmonary bypass (CPB); aortic cross-clamping; cardioplegia (del Nido or Buckberg crystalloid solution commonly used in pediatric centers) for myocardial protection. • Transatrial-Transpulmonary (TAT) Approach: The preferred contemporary technique. The RVOT and VSD are accessed via the right atrium and pulmonary artery, avoiding a right ventriculotomy entirely or limiting it to a minimal incision. This preserves RV muscle mass, reduces late RV dysfunction, and lowers the risk of arrhythmia compared to the traditional right ventriculotomy approach. • Right Ventriculotomy Approach: Reserved for cases with extensive infundibular muscle bundles or anomalous coronary arteries crossing the RVOT that preclude safe TAT access. • VSD Closure: Patch closure using a Dacron patch or autologous glutaraldehyde-treated pericardium with interrupted or continuous polypropylene sutures, ensuring adequate margins to avoid heart block (proximity to the bundle of His). • RVOT Reconstruction Options: a. Pulmonary Valve–Sparing Repair (PVS): Achieved by infundibular muscle resection, pulmonary commissurotomy, and annuloplasty when the pulmonary valve annulus Z-score is ≥ −2. This is the preferred strategy as it preserves valve competence and reduces long-term PR burden. b. Transannular Patch (TAP): Required when the pulmonary annulus Z-score is < −2 to −3. A pericardial or synthetic patch is sutured across the annulus, relieving obstruction but inevitably creating free pulmonary regurgitation. Decision-making is guided by intraoperative assessment using the Nakata index and McGoon ratio. c. RV-to-PA Conduit Implantation: Indicated in TOF with pulmonary atresia or severely anomalous pulmonary valve. Options include cryopreserved homografts (pulmonary or aortic), bovine jugular vein conduits (Contegra™), or porcine-valved conduits. • Intraoperative TEE Monitoring: Mandatory to confirm adequacy of VSD patch closure, assess residual RVOTO (peak gradient < 25–30 mmHg target), evaluate pulmonary valve function, and detect any iatrogenic lesions before chest closure. 3. LATE REINTERVENTION FOR REPAIRED TOF: • Surgical Pulmonary Valve Replacement (PVR): Re-do sternotomy; implantation of a tissue bioprosthesis (e.g., Carpentier-Edwards Perimount, Mosaic) or homograft. Indicated in late PR with RVEDVI > 150–160 mL/m² on CMR or symptomatic RV dysfunction. • Transcatheter Pulmonary Valve Replacement (TPVR): - Melody™ Valve (Medtronic): A bovine jugular vein valve mounted on a platinum-iridium stent; approved for conduit dysfunction in patients with suitable conduit diameter (16–22 mm). - Edwards SAPIEN XT™ / SAPIEN 3™: Balloon-expandable transcatheter valve deployable in native RVOT or large conduits; extends the TPVR option to patients with larger anatomies. - Advantage: Avoids re-do open-heart surgery; shorter hospitalization (2–4 days); same hemodynamic outcomes as surgical PVR in appropriate candidates. • Catheter-Based Interventions: Balloon dilation or stenting of residual/recurrent branch PA stenosis; electrophysiological ablation or ICD implantation for sustained ventricular tachycardia (VT) arising from RVOT scar tissue (a significant cause of late sudden cardiac death in repaired TOF). 4. ADVANCED TECHNOLOGIES AVAILABLE AT PARTNER CENTERS: • High-fidelity 3D cardiac MRI for pre-operative virtual surgical planning • 3D-printed cardiac models for complex anatomies (TOF/PA, TOF/AVSD) • Real-time intraoperative transesophageal echocardiography (TEE) with 3D matrix-array probes • Near-infrared spectroscopy (NIRS) cerebral oximetry monitoring during CPB • Minimally invasive robotic-assisted approaches (investigational in selected ACHD reoperations at advanced centers)
Recovery
PHASE 1 — PRE-OPERATIVE EVALUATION (Days 1–5 in country): • Day 1: GAF Healthcare coordinator receives the patient's medical records remotely and arranges an initial teleconsultation with the designated pediatric cardiac surgeon and congenital cardiologist at the chosen partner hospital. • Days 1–2 (on arrival): Airport reception, hotel or hospital guest house check-in for the patient's family. The patient is admitted to the pediatric cardiac assessment unit. • Days 2–5: Complete diagnostic workup performed in-hospital — transthoracic echocardiography (TTE), cardiac MRI (CMR), CTA of the pulmonary arteries, cardiac catheterization if indicated, 22q11.2 FISH, complete metabolic panel, coagulation profile, blood typing, and crossmatch. Pre-anesthetic evaluation, pediatric anesthesiology consultation, and ICU team briefing. • Day 4–5: Multidisciplinary team (MDT) meeting between cardiac surgery, congenital cardiology, cardiac anesthesia, perfusion, and cardiac nursing. Surgical plan finalized, informed consent obtained in the patient's language (GAF-provided interpreter present). • Baseline weight optimization: Malnourished infants may require 1–2 weeks of pre-operative nasogastric feeding or NG supplementation prior to elective surgery. If urgent, surgery proceeds without delay. PHASE 2 — THE SURGICAL PROCEDURE (Day 6 approximately): • The patient is brought to the operating room (OR) typically in the early morning, fasted for 4–6 hours (clear fluids) or per pediatric anesthesia protocol. • Induction of general anesthesia; arterial line, central venous catheter, urinary catheter, and rectal temperature probe placement. • Median sternotomy; cannulation of the ascending aorta and bicaval venous cannulation for cardiopulmonary bypass (CPB). • Cooling to 28–32°C moderate hypothermia; aortic cross-clamp application; del Nido or Buckberg cardioplegia delivered antegrade. • Transatrial-transpulmonary (TAT) approach: right atriotomy and pulmonary arteriotomy for intracardiac visualization. • Infundibular muscle bundle resection; pulmonary commissurotomy and/or valvotomy; intraoperative measurement of pulmonary annulus diameter versus body surface area (Z-score determination). • VSD patch closure with running 5-0 or 6-0 polypropylene suture and autologous pericardial or Dacron patch. • RVOT augmentation: pulmonary valve–sparing repair if annulus Z-score ≥ −2; otherwise transannular pericardial patch. • De-airing maneuvers; aortic cross-clamp released; cardiac resuscitation; weaning from CPB with inotropic support (dopamine, milrinone — a phosphodiesterase-3 inhibitor that reduces RV afterload and is the pharmacological cornerstone of post-TOF-repair hemodynamic support). • Intraoperative TEE: confirm VSD patch competence (no residual shunt), assess RVOT peak gradient (target < 25 mmHg), evaluate tricuspid valve function. • Pacing wires placed on RV and RA; mediastinal and pericardial chest drains inserted; sternal closure. Total operative time: approximately 3–5 hours. PHASE 3 — PEDIATRIC CARDIAC ICU (PCICU) (Days 1–5 post-op): • Day 0–1 (immediate post-op): Mechanical ventilation; continuous hemodynamic monitoring (arterial line, CVP); milrinone infusion (0.25–0.75 mcg/kg/min) for RV afterload reduction; low-dose dopamine for renal perfusion; strict fluid management to avoid RV volume overload. • Day 1–2: Extubation trials; transition to nasal CPAP or high-flow nasal cannula if tolerated; chest drain output monitoring; pacing wire assessment. • Day 2–3: Successful extubation in uncomplicated cases; oral feeding resumed (breastfeeding or formula for infants); diuretic therapy (furosemide) to manage post-CPB fluid retention; introduction of oral captopril (ACE inhibitor) if residual PR is anticipated. • Day 3–5: Pacing wire removal; chest drain removal; mobilization to the PCICU chair; telemetry for arrhythmia detection (junctional ectopic tachycardia — JET — is the most common post-TOF-repair arrhythmia, managed with amiodarone and cooling). • Echocardiography performed on Day 3–5 to document VSD closure, RVOT gradient, and ventricular function. PHASE 4 — CARDIAC WARD (Days 6–14 post-op): • Transfer from PCICU to the pediatric cardiac ward once hemodynamically stable and off vasoactive infusions. • Gradual increase in oral feeds and activity; weight gain monitoring; wound care for the sternal incision. • Oral medications established: furosemide, spironolactone (potassium-sparing diuretic), captopril, aspirin (antiplatelet therapy per center protocol). • Pre-discharge echocardiogram, 12-lead ECG, chest X-ray. • Day 10–14: Discharge from hospital, contingent on stable hemodynamics, adequate feeding, no arrhythmia, and clean wound. PHASE 5 — IN-COUNTRY RECOVERY (Weeks 3–6 post-op): • The patient and family stay in GAF Healthcare–arranged accommodation near the hospital. • Weekly outpatient review with the congenital cardiologist: clinical examination, oxygen saturation, weight, wound inspection, and echocardiography. • Sternal precautions maintained: no lifting of the child by the arms for 6–8 weeks (lift from the bottom); infant carriers and car seat protocols explained. • Genetic counseling appointment for families with identified 22q11.2 deletion. • By Week 4–6: Repeat echocardiogram and, if required, cardiac MRI to document RV volumes; treating cardiologist issues the formal 'fit-to-fly' clearance letter specifying oxygen supplementation needs (if any) and emergency contact instructions for the flight. PHASE 6 — LONG-TERM FOLLOW-UP (Lifelong): • Annual cardiology review for all repaired TOF patients — minimum every 12–24 months throughout life. • Cardiac MRI every 3–5 years to track RV volumes and pulmonary regurgitant fraction. • QRS duration monitoring on ECG; electrophysiology study (EPS) if QRS > 180 ms. • GAF Healthcare provides a structured telemedicine follow-up plan connecting the patient's home cardiologist with the treating center's ACHD team for the first 12 months post-discharge.
Risks to be aware of
As with all open-heart surgery requiring cardiopulmonary bypass, TOF repair carries a defined set of procedure-specific risks that families must understand in full. The overall 30-day surgical mortality at high-volume centers is 2–5% for primary repair in infants and less than 1% in elective repair of older children; however, risk is significantly higher in neonates under 2.5 kg, patients with TOF/pulmonary atresia with major aortopulmonary collateral arteries (MAPCAs), and those with associated 22q11.2 deletion (increased susceptibility to hypocalcemia, immunodeficiency, and infection). Specific procedural risks include: (1) Residual or recurrent VSD — reported in 3–5% of cases, may require catheter-based device closure or reoperation if hemodynamically significant (Qp:Qs > 1.5). (2) Complete heart block — caused by inadvertent injury to the atrioventricular conduction system during VSD patch placement; occurs in <1–2% of experienced hands but requires permanent pacemaker implantation if persistent beyond 7–14 days. (3) Junctional Ectopic Tachycardia (JET) — the most common post-operative arrhythmia (5–15%), typically transient, managed with amiodarone and controlled hypothermia. (4) Right ventricular failure — resulting from inadequate myocardial protection, residual RVOTO, or severe pre-operative RV hypertrophy; managed with milrinone, sildenafil (a pulmonary vasodilator), and in refractory cases, mechanical circulatory support (ECMO). (5) Pulmonary hypertensive crisis — more likely in older, unrepaired patients or those with elevated pre-operative pulmonary pressures; prevented with inhaled nitric oxide (iNO) post-operatively. (6) Neurological injury — cerebral air embolism or embolic stroke is rare (<1%) with modern de-airing techniques and neuromonitoring (NIRS). (7) Long-term pulmonary regurgitation — the most significant late complication following transannular patch repair, present in 70–80% of such patients, leading to progressive RV dilation and requiring pulmonary valve replacement in 10–15% of patients within 20 years. (8) Late sudden cardiac death — estimated risk of 0.2% per patient-year in repaired TOF; strongly associated with QRS duration > 180 ms, sustained VT, and severe RV dysfunction. Electrophysiological study and ICD implantation are considered in high-risk patients. All GAF Healthcare partner centers have documented complication management protocols, extracorporeal membrane oxygenation (ECMO) availability, and 24/7 pediatric cardiac intensivist coverage.
Why GAF Healthcare
GAF Healthcare provides end-to-end non-medical support designed specifically for international pediatric cardiac patients, removing administrative burden from families at their most stressful time. VISA & ENTRY ASSISTANCE: • India: GAF Healthcare's patient relations team facilitates the Indian e-Medical Visa application (available to citizens of 156 countries) for the patient and up to two accompanying attendants (e-Medical Attendant Visa). Applications are processed online through the Indian government portal; typical approval time is 3–5 business days. GAF provides a formal hospital invitation letter and all required documentation in the prescribed format. • UAE (Dubai / Abu Dhabi): Citizens of GCC countries, the EU, UK, USA, Canada, and Australia receive visa-free or visa-on-arrival access. Patients from other nationalities receive coordination support for a Medical Treatment Visa or a standard UAE entry visa, including hospital treatment confirmation letters accepted by UAE immigration authorities. UAE Health Authority (DHA/DOH) requirements for patient admission are pre-cleared by GAF's UAE operations team. AIRPORT & GROUND TRANSFERS: • Dedicated air-conditioned ambulance or accessible vehicle transfer from the international airport to the hospital on arrival, available 24/7. A GAF patient coordinator is physically present at the airport arrivals hall bearing a name board. • All subsequent inter-facility transfers (hospital to guest house, outpatient clinic visits) are coordinated and included in the GAF patient package. MEDICAL TRANSLATION & INTERPRETATION: • Dedicated medical interpreters available for Arabic, Russian, French, Swahili, Bengali, Amharic, Pashto, and other major languages — present during all physician consultations, surgical consent discussions, discharge briefings, and pharmacy counseling sessions. • All discharge summaries, surgical reports, echocardiography reports, and medication lists are provided in both English and the patient's native language. ACCOMMODATION FOR ATTENDANTS: • Hospital guest houses or GAF-partnered serviced apartments within 1–2 km of the treating hospital are arranged for the patient's family (typically 2 attendants for a pediatric patient). • Accommodation includes basic cooking facilities, Wi-Fi, laundry access, and local SIM cards for communication. • For prolonged stays (4–6 weeks), GAF negotiates discounted long-stay rates and arranges grocery delivery and meal services suited to the family's dietary requirements. FINANCIAL COORDINATION: • GAF Healthcare provides itemized, transparent all-inclusive package quotes covering surgery, anesthesia, PCICU, ward stay, standard medications, post-operative echocardiography, and routine lab work — enabling families to plan travel budgets with certainty. • Facilitation of insurance pre-authorization letters for patients with international health insurance coverage. • Telemedicine follow-up subscription connecting the patient's home cardiologist with the treating ACHD team post-discharge, included in the GAF post-care package for 12 months.
Common questions about Tetralogy of Fallot (TOF)
What is the cost of Tetralogy of Fallot (TOF) repair in India vs. the UAE?
How long do we need to stay in the country before the child is fit to fly home?
What is the success rate of TOF repair, and what are the long-term outcomes?
How GAF Healthcare Assists in Choosing the Best Hospital for Tetralogy of Fallot (TOF) in Bengaluru, India
Discover the Top Hospitals for Tetralogy of Fallot (TOF) in Bengaluru, India
This page lists 10 accredited paediatric cardiology hospitals in Bengaluru, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about tetralogy of fallot (tof) in Bengaluru, India
How many paediatric cardiology hospitals are listed in Bengaluru, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there paediatric cardiology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for tetralogy of fallot (tof) in Bengaluru, India.
Contact us to report an inaccuracy on this page.